Treatment strategies for huge central neurocytomas.
10.1007/s11596-015-1397-2
- Author:
Zhong-wei XIONG
1
;
Jian-jian ZHANG
;
Ting-bao ZHANG
;
Shou-jia SUN
;
Xiao-lin WU
;
Hao WANG
;
Chao YOU
;
Yu WANG
;
Hua-qiu ZHANG
;
Jin-cao CHEN
Author Information
1. Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China, xzw870206@126.com.
- Publication Type:Journal Article
- MeSH:
Antineoplastic Agents;
therapeutic use;
Combined Modality Therapy;
Humans;
Neurocytoma;
therapy;
Radiotherapy;
Surgical Procedures, Operative
- From:
Journal of Huazhong University of Science and Technology (Medical Sciences)
2015;35(1):105-110
- CountryChina
- Language:English
-
Abstract:
Central neurocytomas (CNs), initially asymptomatic, sometimes become huge before detection. We described and analyzed the clinical, radiological, operational and outcome data of 13 cases of huge intraventricular CNs, and discussed the treatment strategies in this study. All huge CNs (n=13) in our study were located in bilateral lateral ventricle with diameter ≥5.0 cm and had a broad-based attachment to at least one side of the ventricle wall. All patients received craniotomy to remove the tumor through transcallosal or transcortical approach and CNs were of typical histologic and immunohistochemical features. Adjuvant therapies including conventional radiation therapy (RT) or gamma knife radiosurgery (GKRS) were also performed postoperatively. Transcallosal and transcortical approaches were used in 8 and 5 patients, respectively. Two patients died within one month after operation and 3 patients with gross total resection (GTR) were additionally given a decompressive craniectomy (DC) and/or ventriculoperitoneal shunt (VPS) as the salvage therapy. Six patients received GTR(+RT) and 7 patients received subtotal resection (STR)(+GKRS). Eight patients suffered serious complications such as hydrocephalus, paralysis and seizure after operation, and patients who underwent GTR showed worse functional outcome [less Karnofsky performance scale (KPS) scores] than those having STR(+GKRS) during the follow-up period. The clinical outcome of huge CNs seemed not to be favorable as that described in previous reports. Surgical resection for huge CNs should be meticulously considered to guarantee the maximum safety. Better results were achieved in STR(+GKRS) compared with GTR(+RT) for huge CNs, suggesting that STR(+GKRS) may be a better treatment choice. The recurrent or residual tumor can be treated with GKRS effectively.